FeesSafety
Pluang+

Arthur Hayes warns Bitcoin may drop to $50K before surging past $1M amid AI bubble and government bailout.

Market News
09 Aug 2026
Bitcoin
View Source
Neutral
Arthur Hayes warns Bitcoin may drop to $50K before surging past $1M amid AI bubble and government bailout.

Arthur Hayes, co-founder of Bitmex, compares the AI infrastructure boom to a real estate credit bubble that could trigger a government bailout larger than 2008. He predicts Bitcoin may decline to around $50,000 as liquidity shifts to AI investments but expects a massive liquidity injection from the government to eventually push Bitcoin beyond $1 million. Hayes foresees AI capital spending slowing by 2027-2028, with the credit bubble bursting years later, driving significant market intervention and liquidity creation that benefits Bitcoin's long-term price surge.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
28 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App